References
- Mathes SJ: Plastic surgery. Saunders Elsevier Company; 2006;209-234
- Melo MD, Obeid G: Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition J Am Dent Assoc 2005;136(12): 1675-8 https://doi.org/10.14219/jada.archive.2005.0110
- Marx RE: Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 2003;61:1115-7 https://doi.org/10.1016/S0278-2391(03)00720-1
- Hoff A: Expert panel recommendation for prevention, diagnosis,and treatment of osteonecrosis of the jaws Oncology Drug Advisory Committee Meeting East Hanover, NJ, Novartis, March 4, 2005
- Bamias A, Kastritis E, Bamia C, et al: Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 2005;23:8580-7 https://doi.org/10.1200/JCO.2005.02.8670
- Marx RE: Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention, and treatment Hanover Park(IL) Quintessence Publsihing 2006
- American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 2007; 65:369-76
- Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB: Managing the care of patients with bis phosphonate associated osteonecrosis: an American Academy of Oral Medicine position paper J Am Dent Assoc 2005;136(12):1658-68 https://doi.org/10.14219/jada.archive.2005.0108
- Catalano L, Del Vecchio S, Petruzzie llo F, et al: Sestamibi and FDGPET scans to support diagnosis of jaw osteonecrosis Ann Hematol 2007;86(6):415-23 https://doi.org/10.1007/s00277-007-0263-0
- Russell RG: Bisphosphonates: mode of action and pharmacology Pediatrics 2007;119 Suppl 2:S150-62 https://doi.org/10.1542/peds.2006-2023H
- Roelofs AJ, Thompson K, Gordon S, Rogers MJ: Molecular mechanisms of action of bisphosphonates: current status Clin Cancer Res 2006;12(20 Pt 2):6222-30 https://doi.org/10.1158/1078-0432.CCR-06-0843
- Mavrokokki T, Cheng A, Stein B, Goss A: Nature and frequency of bisphosphonateassociated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 2007;65(3):415-23 https://doi.org/10.1016/j.joms.2006.10.061
- Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D,Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid Haematologica 2006;91(7):968-71
- Yoh Sawatari, Robert E: Marx, Bisphosphonates and Bisphosphonate Induced Osteonecrosis Oral Maxillofacial Surg Clin N Am 2007;19:487-98 https://doi.org/10.1016/j.coms.2007.07.003
- Marx RE, Sawatari Y, Fortin M, Broumand:. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 2005;63(11):1567-75 https://doi.org/10.1016/j.joms.2005.07.010
- Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, Elad S: Possible association between diabetes and bisphosphonate- related jaw osteonecrosis J Clin Endocrinol Metab 2007;92(3):1172-5 https://doi.org/10.1210/jc.2006-2036
- Ardine M, Generali D, Donadio M, Bonardi S, Scoletta M, Vandone AM et al: Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw? Ann Oncol 2006; 17(8):1336-7 https://doi.org/10.1093/annonc/mdl045
- Hellstein JW, Marek CL: Bisphospho nate osteochemonecrosis (bis-phossy jaw):is this phossy jaw of the 21st century J Oral Maxillofac Surg 2005;63(5):682-9 https://doi.org/10.1016/j.joms.2005.01.010
- Van den Wyngaert T, Huizing MT, Vermorken JB: Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy Ann Oncol 2006; 17(8):1197-204 https://doi.org/10.1093/annonc/mdl294
- Courtney PA, Hosking DJ, Fairbairn K J, Deighton CM: Treatment of SAPHO with pamidronate. Rheumatology 2002; 41:1196-8 https://doi.org/10.1093/rheumatology/41.10.1196
- Marx RE: Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws. History, etiology, prevention, and treatment. Quintessence Publishing Co Inc; 2007;9-96
- Advisory Task Force on Bisphospho nate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillo facial Surgeons position paper on bis phosphonate-related osteo necrosis of the jaws. J Oral Maxillofac Surg 2007;65(3):369-76 https://doi.org/10.1016/j.joms.2006.11.003
- Jeffcoat MK: Safety of oral bisphosphonates: Controlled studies on alveolar bone Int J Oral Maxillofac Implants 2006;21:349
- Bao-Thy Grant, Chistopher Amenedo: Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases J Oral Maxillofac Surg 2008;66:223-230 https://doi.org/10.1016/j.joms.2007.09.019
- Starck WJ, Epker BN: Failure of osteointegrated dental implants after diphosphonate therapy for osteoporosis: A case report Int J Oral Mxillofac Implants 1995;10:74-8